349 related articles for article (PubMed ID: 15695382)
1. Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.
Wu K; Hinson SR; Ohashi A; Farrugia D; Wendt P; Tavtigian SV; Deffenbaugh A; Goldgar D; Couch FJ
Cancer Res; 2005 Jan; 65(2):417-26. PubMed ID: 15695382
[TBL] [Abstract][Full Text] [Related]
2. Effect of the overexpression of BRCA2 unclassified missense variants on spontaneous homologous recombination in human cells.
Balia C; Galli A; Caligo MA
Breast Cancer Res Treat; 2011 Oct; 129(3):1001-9. PubMed ID: 21671020
[TBL] [Abstract][Full Text] [Related]
3. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.
Chenevix-Trench G; Healey S; Lakhani S; Waring P; Cummings M; Brinkworth R; Deffenbaugh AM; Burbidge LA; Pruss D; Judkins T; Scholl T; Bekessy A; Marsh A; Lovelock P; Wong M; Tesoriero A; Renard H; Southey M; Hopper JL; Yannoukakos K; Brown M; Easton D; Tavtigian SV; Goldgar D; Spurdle AB;
Cancer Res; 2006 Feb; 66(4):2019-27. PubMed ID: 16489001
[TBL] [Abstract][Full Text] [Related]
4. Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.
Spurdle AB; Lakhani SR; Healey S; Parry S; Da Silva LM; Brinkworth R; Hopper JL; Brown MA; Babikyan D; Chenevix-Trench G; Tavtigian SV; Goldgar DE;
J Clin Oncol; 2008 Apr; 26(10):1657-63. PubMed ID: 18375895
[TBL] [Abstract][Full Text] [Related]
5. Chinese hamster cell mutant, V-C8, a model for analysis of Brca2 function.
Wiegant WW; Overmeer RM; Godthelp BC; van Buul PP; Zdzienicka MZ
Mutat Res; 2006 Aug; 600(1-2):79-88. PubMed ID: 16643964
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice.
Donoho G; Brenneman MA; Cui TX; Donoviel D; Vogel H; Goodwin EH; Chen DJ; Hasty P
Genes Chromosomes Cancer; 2003 Apr; 36(4):317-31. PubMed ID: 12619154
[TBL] [Abstract][Full Text] [Related]
7. cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutation.
Zhang L; Bacares R; Boyar S; Hudis C; Nafa K; Offit K
Mutat Res; 2009 Apr; 663(1-2):84-9. PubMed ID: 19070627
[TBL] [Abstract][Full Text] [Related]
8. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
[TBL] [Abstract][Full Text] [Related]
9. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
[TBL] [Abstract][Full Text] [Related]
10. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk assessment at the atomic level.
Monteiro AN; Couch FJ
Cancer Res; 2006 Feb; 66(4):1897-9. PubMed ID: 16488985
[TBL] [Abstract][Full Text] [Related]
12. BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis.
Abaji C; Cousineau I; Belmaaza A
Cancer Res; 2005 May; 65(10):4117-25. PubMed ID: 15899802
[TBL] [Abstract][Full Text] [Related]
13. Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer.
Wappenschmidt B; Fimmers R; Rhiem K; Brosig M; Wardelmann E; Meindl A; Arnold N; Mallmann P; Schmutzler RK
Breast Cancer Res; 2005; 7(5):R775-9. PubMed ID: 16168123
[TBL] [Abstract][Full Text] [Related]
14. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
[TBL] [Abstract][Full Text] [Related]
15. Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.
Lovelock PK; Wong EM; Sprung CN; Marsh A; Hobson K; French JD; Southey M; Sculley T; Pandeya N; Brown MA; Chenevix-Trench G; Spurdle AB; McKay MJ;
Breast Cancer Res Treat; 2007 Sep; 104(3):257-66. PubMed ID: 17063265
[TBL] [Abstract][Full Text] [Related]
16. Conserved domains in the chicken homologue of BRCA2.
Takata M; Tachiiri S; Fujimori A; Thompson LH; Miki Y; Hiraoka M; Takeda S; Yamazoe M
Oncogene; 2002 Feb; 21(7):1130-4. PubMed ID: 11850831
[TBL] [Abstract][Full Text] [Related]
17. RNA-based analysis of BRCA1 and BRCA2 gene alterations.
Bonatti F; Pepe C; Tancredi M; Lombardi G; Aretini P; Sensi E; Falaschi E; Cipollini G; Bevilacqua G; Caligo MA
Cancer Genet Cytogenet; 2006 Oct; 170(2):93-101. PubMed ID: 17011978
[TBL] [Abstract][Full Text] [Related]
18. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.
Akbari MR; Malekzadeh R; Nasrollahzadeh D; Amanian D; Islami F; Li S; Zandvakili I; Shakeri R; Sotoudeh M; Aghcheli K; Salahi R; Pourshams A; Semnani S; Boffetta P; Dawsey SM; Ghadirian P; Narod SA
Oncogene; 2008 Feb; 27(9):1290-6. PubMed ID: 17724471
[TBL] [Abstract][Full Text] [Related]
19. Structure-based assessment of BRCA1 and BRCA2 mutations in a small Spanish population.
Salgado J; Zabalegui N; García-Amigot F; Gil MC; González MS; García-Foncillas J
Oncol Rep; 2005 Jul; 14(1):85-8. PubMed ID: 15944772
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of variants of unknown significance in the BRCA2 gene].
Heczková M; Macháčková E; Jirsa M; Spičák J; Foretová L; Hucl T
Klin Onkol; 2012; 25 Suppl():S87-95. PubMed ID: 22920214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
